Al Platform

Development of a cell-specific AAV production platform (CARE™)
using machine learning-based artificial intelligence (AI) (patent pending)

  • Development of a platform to develop AAV that improves cell targeting through Meta analysis based on more than 5 billion literature information

  • Development of new serotype AAVs with improved cell targeting improves drug efficacy and reduces side effects

  • AAV design for various diseases is possible by controlling AAV's ability to target and de-target cells